Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Sees Large Decline in Short Interest

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) was the target of a significant decline in short interest in the month of August. As of August 14th, there was short interest totaling 118,989 shares, a decline of 47.0% from the July 30th total of 224,453 shares. Based on an average daily volume of 157,426 shares, the short-interest ratio is presently 0.8 days. Approximately 0.0% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Separately, Kepler Capital Markets raised Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Coloplast A/S Price Performance

OTCMKTS CLPBY opened at $7.17 on Monday. The business has a 50 day simple moving average of $6.44 and a 200 day simple moving average of $6.60. Coloplast A/S has a 52-week low of $5.64 and a 52-week high of $10.03. The company has a debt-to-equity ratio of 1.66, a quick ratio of 1.09 and a current ratio of 1.75. The stock has a market cap of $16.16 billion, a price-to-earnings ratio of 37.74, a PEG ratio of 2.70 and a beta of 0.13.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, August 18th. The company reported $0.10 EPS for the quarter, hitting the consensus estimate of $0.10. Coloplast A/S had a net margin of 9.68% and a return on equity of 38.81%. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.11 billion. Analysts anticipate that Coloplast A/S will post 0.4 earnings per share for the current fiscal year.

Coloplast A/S Company Profile

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.